GENESYS.NSGENESYS.NSNSE

Revenue (LTM)

$3.1B

+56.9% YoY

Net Income (LTM)

$562M

+154.7% YoY

Free Cash Flow

$-621M

Revenue CAGR (5Y)

+24.2%

Marginsimproving

FCF($0.6B)

Profitable

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Revenue	796	1,165↑46.4%	1,811↑55.5%	1,982↑9.4%	3,110↑56.9%
Gross Profit	169	358↑111.9%	777↑116.9%	989↑27.3%	1,144↑15.6%
Operating Income	-198	63↑132.0%	216↑240.7%	371↑72.2%	871↑134.6%
Net Income	-429	134↑131.2%	191↑42.2%	221↑15.7%	562↑154.7%
EBITDA	-326	-143↑56.2%	651↑556.7%	862↑32.3%	1,465↑69.9%
EPS Diluted	-13.77	4.01↑129.1%	5.27↑31.4%	5.74↑8.9%	14.03↑144.4%

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Cash & Equivalents	12	215↑1730.2%	126↓41.5%	233↑85.2%	33↓85.6%
Total Current Assets	753	1,280↑70.1%	2,434↑90.1%	3,313↑36.1%	4,551↑37.4%
Total Assets	3,041	3,214↑5.7%	5,056↑57.3%	6,346↑25.5%	7,780↑22.6%
Total Current Liabilities	367	731↑98.8%	691↓5.4%	1,089↑57.6%	1,892↑73.8%
Total Liabilities	492	855↑73.9%	981↑14.8%	1,438↑46.6%	2,209↑53.6%
Total Equity	1,733	2,048↑18.2%	4,054↑97.9%	4,892↑20.7%	5,555↑13.6%
Total Debt	136	265↑94.8%	393↑48.4%	595↑51.4%	1,222↑105.3%
Net Debt	124	50↓59.6%	268↑433.1%	363↑35.5%	1,043↑187.6%

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Operating Cash Flow	288	281↓2.5%	-352↓225.2%	191↑154.2%	-584↓406.5%
Capital Expenditure	-166	-225↓35.5%	-980↓334.9%	-836↑14.6%	-37↑95.6%
Free Cash Flow	122	50↓59.4%	-1,332↓2787.9%	-646↑51.5%	-621↑3.8%
Stock-Based Comp	-2	14↑808.6%	27↑88.3%	32↑17.6%	0
Net Change in Cash	-14	200↑1576.2%	-88↓144.1%	107↑221.4%	-591↓651.8%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance